Financial Guidance Group Inc. Has $318,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Financial Guidance Group Inc. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 782 shares of the company’s stock after selling 79 shares during the quarter. Financial Guidance Group Inc.’s holdings in HCA Healthcare were worth $318,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at $231,000. New Mexico Educational Retirement Board raised its stake in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $566,000. Bessemer Group Inc. grew its stake in shares of HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares during the period. Finally, Empowered Funds LLC grew its holdings in HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock worth $5,747,945 in the last three months. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $398.90 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market cap of $104.48 billion, a PE ratio of 19.89, a P/E/G ratio of 1.44 and a beta of 1.67. The business’s 50-day simple moving average is $394.72 and its two-hundred day simple moving average is $352.30. HCA Healthcare, Inc. has a 52 week low of $220.55 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.29 earnings per share. As a group, analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on HCA shares. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, Morgan Stanley started coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $367.15.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.